• MT49 Cost-Effectiveness Analysis of Farapulse™ Pulsed Field Ablation (PFA) in Patients with Paroxysmal Atrial Fibrillation

    Dec 1, 2023, 00:00

  • OP3 Single-Use Vs Reusable Endoscopy Reprocessing: An Efficiency Survey of Nurses and Technicians

    Dec 1, 2023, 00:00

  • EE212 Understanding Service Use for Melanoma in the UK National Health Servi An Expert Elicitation Exercise Using a New Method for Eliciting Proportions

    Dec 1, 2023, 00:00

  • MSR10 Incidence, Prevalence, and Clinical Characteristics of Patients with Chronic Lymphocytic Leukemia (CLL) in Spain: Natural Language Processing (NLP) Analysis of Electronic Health Records (EHRs)

    Dec 1, 2023, 00:00

  • P36 Towards a Collaborative Value Assessment Framework for Provider-Facing Digital Health Technologies Used in Chronic Disease Management: Findings and Implications

    Dec 1, 2023, 00:00

  • PT7 Data Standardization in Brazil: An OMOP Common Data Model Approach in a DATASUS Cohort

    Dec 1, 2023, 00:00

  • PCR202 Atoderma: Clinical and Economic Burden of Moderate to Severe Atopic Dermatitis in the Czech Republic

    Dec 1, 2023, 00:00

  • HPR73 Underfunding of Public Health System and Unmet Dental Needs Among the European Elderly Population

    Dec 1, 2023, 00:00

  • HTA210 Characteristics and Outcomes of Health Technology Assessment Submissions for Advanced Therapy Medicinal Products in Europe: Perspective From Non-EU5 Countries

    Dec 1, 2023, 00:00

  • OP21 A Validated Dutch Translation of the CHEERS II Statement

    Dec 1, 2023, 00:00

  • HTA273 Managed Access Agreements in the UK: A Detailed Analysis of NICE's Utilization and Impact on Access

    Dec 1, 2023, 00:00

  • EPH51 Artificial Intelligence (AI) Tools for Outbreak Detection and Response: A Transnational Platform for Surveillance, Monitoring and Decision Support

    Dec 1, 2023, 00:00

  • PCR233 Socioeconomic Impact of Muscular Dystrophies on Patients and Their Caregivers in the Czech Republic

    Dec 1, 2023, 00:00

  • EPH94 Comparative Analysis of Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus: A Nationwide US Medicare Perspective

    Dec 1, 2023, 00:00

  • RWD176 Economic Results Generated By Optimizing a Parenteral Medication Application Process

    Dec 1, 2023, 00:00

  • EE691 Economic Evaluation and Budget Impact of RVd as Induction Regimen Prior to ASCT in Patients with Newly Diagnosed Multiple Myeloma from the Perspective of the Public Health Sector in Mexico

    Dec 1, 2023, 00:00

  • HTA234 How Long Is the Weight? A Framework for Linear Interpolation of the National Institute for Health and Care Excellence (NICE) Severity Weighting in the Context of Probabilistic Sensitivity Analysis (PSA): A Case Study

    Dec 1, 2023, 00:00

  • HSD49 Impact of Endoscope Choice on Nurse Time in GI Surgical Procedures: A Prospective Study in a Danish University Hospital

    Dec 1, 2023, 00:00

  • HPR72 Regulation and Reality of the Market Access Process for Digital Health Applications (DiGA) in Germany

    Dec 1, 2023, 00:00

  • HPR127 Corporate Social Responsibility in Health Technology Industry, in Greece

    Dec 1, 2023, 00:00

  • SA76 Systematic Literature Review on Economic Burden of Retinitis Pigmentosa (RP) and Visual Impairment in France

    Dec 1, 2023, 00:00

  • PCR222 Safety and Quality of Life of Various Artificial Pancreas Systems in Patients With Type 1 Diabetes Mellitus: A Systematic Review of Real-World Evidence

    Dec 1, 2023, 00:00

  • Faster Diagnosis and Treatment for Cancer: Assessing Patient Pathways Using a Panel Regression Analysis of the English National Cancer Registration Data [Editor's Choice]

    Dec 1, 2023, 00:00

  • EE493 Healthcare Resource Utilization Associated with Major Depressive Disorder with Insomnia Symptoms: A Retrospective Cohort Study in Hungary

    Dec 1, 2023, 00:00

  • EE247 Emicizumab is Cost-Saving for Finnish Hemophilia A Patients with Factor VIII Inhibitors

    Dec 1, 2023, 00:00

  • EE590 Assessing Health Outcomes and Cost-Effectiveness of Adult HPV Vaccination in Italy

    Dec 1, 2023, 00:00

  • HTA164 Implementing Combination Treatment Cost-Effectiveness Solutions Beyond the Legal Challenges – What Else Needs to be in Place?

    Dec 1, 2023, 00:00

  • RWD75 An Innovative Data Collection System for Improving Outcomes in Patients Treated with Diabetes Technology

    Dec 1, 2023, 00:00

  • SA70 Clinical Benefits and Cost-Effectiveness of High-Dose Capsaicin Cutaneous Patches for Peripheral Neuropathic Pain: A Literature Review

    Dec 1, 2023, 00:00

  • EE661 The Quality of Economic Evaluations of Breast Cancer for Diagnostics, Screening, and Therapeutics in the Middle East: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • EE686 Cost Effectiveness of Ruxolitinib for Treatment of Steroid Refractory Acute Graft Versus Host Disease in Patients >12 Years of Age from a Singapore Healthcare System Perspective

    Dec 1, 2023, 00:00

  • HSD119 Patient Pathways, Genetic Testing, and Diagnosis of X-Linked Retinitis Pigmentosa in Europe: Insights from the Cross-Sectional Explore Xlrp-1.2 Physician Survey

    Dec 1, 2023, 00:00

  • HTA323 Analyzing Historic Health Technology Assessments (HTAs): Surrogate Endpoints (SEs) in the Interstitial Pneumonia With Autoimmune Features (IPF)/Interstitial Lung Disease (ILD) Therapeutic Domain

    Dec 1, 2023, 00:00

  • EE424 Cost-Utility and Budget Impact Analyses of Tumor Necrosis Factor Inhibitor Biologics and Biosimilars Versus Rituximab in Thai Patients with Active Rheumatoid Arthritis

    Dec 1, 2023, 00:00

  • SA80 Priors on Between-Study Heterogeneity in Bayesian Meta-Analysis Models: A Simulation Study Using Hamiltonian Monte Carlo Sampling

    Dec 1, 2023, 00:00

  • RWD168 Epidemiology of Respiratory Syncytial Virus in Uppsala and Stockholm: A Population-Based Study

    Dec 1, 2023, 00:00

  • EE569 Cost-Effectiveness of Eftrenonacog Alfa in Treatment of Severe Haemophilia B Patients in Turkey

    Dec 1, 2023, 00:00

  • MT70 Robotic-Assisted Surgery Versus Open Surgery in Endometrial Cancer: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • EE540 Cost-Effectiveness of Brexucabtagene Autoleucel for the Treatment of Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Patients Aged 26 Years or Older in the United Kingdom

    Dec 1, 2023, 00:00

  • EE360 Clinical and Economic Evaluation of Atezolizumab Versus Durvalumab Administration in Adult Patients with Extensive Stage Small Cell Lung Cancer

    Dec 1, 2023, 00:00

  • EE344 Cost per Responder Associated with Bimekizumab Against Il-17A-Inhibitors in the Treatment of Axial Spondyloarthritis in Sweden

    Dec 1, 2023, 00:00

  • PT48 International Reference Pricing Analysis of Medicines in Turkiye By 2022

    Dec 1, 2023, 00:00

  • RWD159 Comparison of Livingstone's Estimates of Prevalence of Six Different Rare Blood Cancers with Darwin EU

    Dec 1, 2023, 00:00

  • HTA366 NICE Technology Appraisals Based on Single-Arm Trials in 2022 – What Can We Learn from Them?

    Dec 1, 2023, 00:00

  • EE149 Surge Capacity for Preserving Accessibility to Primary Healthcare Services during the COVID19 Pandemic in a Middle Income Country

    Dec 1, 2023, 00:00

  • PCR176 Establishing the Interchangeability Between CSF and PET to Identify Patients With Alzheimer's Disease Pathology

    Dec 1, 2023, 00:00

  • HPR10 Added Benefit and Revenues of Oncology Drugs Approved By the European Medicines Agency between 1995 and 2020

    Dec 1, 2023, 00:00

  • HPR219 "Direct Access" Experiment in Fran Potential Impact on the Pricing of Innovative Medicines

    Dec 1, 2023, 00:00

  • HSD118 Patient Safety in Oncology: Quantifying the Hospital-Associated Risks with a Discrete-Events Simulation

    Dec 1, 2023, 00:00

  • HTA35 G-BA Vs. InEK: Navigating Divergent Requirements Between the Two Key Bodies Behind Inpatient Drug Reimbursement in Germany

    Dec 1, 2023, 00:00

  • EE423 The Cost Savings Potential Associated with the Use of Nefecon for Adults with Primary IgA Nephropathy in the United States

    Dec 1, 2023, 00:00

  • PCR115 Health-Related Quality of Life Associated With Common Stoma Complications—Peristomal Skin Complications and Leakages Onto Clothes

    Dec 1, 2023, 00:00

  • SA41 Novel Method for Indirect Comparison of Treatment Sequences Using Averaged Parametric Survival Models with Application to Hepatocellular Carcinoma

    Dec 1, 2023, 00:00

  • MSR102 Advancing Causal Inference With Machine Learning and Real-World Data: An Application of Targeted Machine Learning and Super Learners on Hospital-Acquired Pressure Injuries From MIMIC IV

    Dec 1, 2023, 00:00

  • HSD52 Employess Satisfaction Level from Working Conditions at the Public Psychiatric Hospital of Athens, Greece

    Dec 1, 2023, 00:00

  • HPR71 All Back to Square One: What Follows from the New Algorithm for Drug Pricing in Germany?

    Dec 1, 2023, 00:00

  • PCR114 The Association Between Health-Related Quality of Life and Social Determinants of Health for Diabetes in Japan: A Cross-Sectional Patient Survey

    Dec 1, 2023, 00:00

  • EE64 Change in Healthcare Resource Use and Associated Costs of Patients with Metastatic Lung Cancer between 2013 and 2019: An Observational Study from the French National Claims Database

    Dec 1, 2023, 00:00

  • PCR89 Predicting EQ-5D-5L Score by Using SGRQ in Patients with Asthma and/or COPD in NOVELTY

    Dec 1, 2023, 00:00

  • EE588 The Budget Impact of Introducing Robotic-Assisted Surgery for Spinal Fusion Procedures in Spain

    Dec 1, 2023, 00:00

  • EE187 Use of Resources and Economic Cost of People Living with HIV in the Brazilian Supplementary Health System

    Dec 1, 2023, 00:00

  • EE469 Diabetic Retinopathy in Algeria: Costs Estimation and Medical-Economic Value of Automated Methods AI-Based in Early Screening

    Dec 1, 2023, 00:00

  • EE447 Working With Probabilistic Models for Cost-Effectiveness Analysis: Computational Tools Integrating Exact Methods vs Simulation-Based Approaches

    Dec 1, 2023, 00:00

  • MT3 Intracardiac Echocardiography Operational Experience of Chinese Interventional Cardiologists in Conducting Radio-Frequency Catheter Ablation for Cardiac Arrhythmias: A Cross-Sectional Survey Study

    Dec 1, 2023, 00:00

  • EE127 CAR-T Cell Therapies' Pathway: Evolution of Management and of Costing Methodology in the French Cost-Effectiveness Analyses (CEA) Landscape

    Dec 1, 2023, 00:00

  • EE416 The Cost-Effectiveness of WaveWriter Alpha Spinal Cord Stimulation System in a Swedish Setting

    Dec 1, 2023, 00:00

  • PCR248 Meaningful Within-Patient Change Threshold Range for the FACIT-Fatigue in Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Dec 1, 2023, 00:00

  • HSD117 Healthcare Resources Utilization (HCRU) and Exploration of the Patient Journey through Claims Database: An Application on Advanced Renal Cell Carcinoma (ARCC) Patients in France

    Dec 1, 2023, 00:00

  • EE319 Update to the Macrovascular Submodels of the IQVIA Core Diabetes Model

    Dec 1, 2023, 00:00

  • MSR64 How Is Machine Learning Being Used in HEOR? A Systematic Review of Trends and Methods

    Dec 1, 2023, 00:00

  • HTA70 The Italian Healthcare System Competences in View of the New European HTA Regulation

    Dec 1, 2023, 00:00

  • CO45 A Systematic Review of Quality of Life and Gastroesophageal Reflux Disease

    Dec 1, 2023, 00:00

  • PCR6 Impact of Perianal Fistulas on Crohn’s Disease Patients

    Dec 1, 2023, 00:00

  • EE258 Healthcare Resource Utilization and Economic Burden of Hidradenitis Suppurativa in German Patients with Hidradenitis Suppurativa

    Dec 1, 2023, 00:00

  • HTA332 Evaluating Transcatheter Valve Replacement in Tricuspid Regurgitation: Complexities and Limitations of Existing Models

    Dec 1, 2023, 00:00

  • EE607 Development of an Online Database of Published Usable Mapping Algorithms Used to Estimate EQ-5D Utilities

    Dec 1, 2023, 00:00

  • EE671 Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment for Renal Cell Carcinoma Post-Nephrectomy in France

    Dec 1, 2023, 00:00

  • EE283 Value of Information Analyses for Advanced Cell Therapies: A Systematic Review

    Dec 1, 2023, 00:00

  • RWD162 Evolution of Breast Cancer Treatment Cost in the Last 36 Months: An Analysis From a Health Payer Perspective in Brazil

    Dec 1, 2023, 00:00

  • HSD109 What Are the Main Challenges in Management Care of Stoma Patients in Fran Guidelines from Shield Multidisciplinary Experts for Optimization

    Dec 1, 2023, 00:00

  • EE259 The Societal Cost of Age-Related Macular Degeneration and Diabetic Macular Edema: An Estimation Using a Pragmatic Literature Review

    Dec 1, 2023, 00:00

  • CO144 A Trial-Based Health Utility Analysis in Patients with Acanthamoeba Keratitis

    Dec 1, 2023, 00:00

  • PCR97 Impact of Paroxysmal Nocturnal Haemoglobinuria on Employment and Activity: Results from a Real-World Study

    Dec 1, 2023, 00:00

  • RWD85 A Systematic Literature Review on the Use of Real-World Evidence in NICE Technology Appraisals Indicated for Multiple Myeloma

    Dec 1, 2023, 00:00

  • EE25 Cost-Effectiveness Analysis of S-Adenosylmethionine for the Treatment of Intrahepatic Cholestasis in China

    Dec 1, 2023, 00:00

  • HTA207 Can We Speak to GPT to Inform Health Technology Assessments?

    Dec 1, 2023, 00:00

  • HTA130 Different Approaches to the Health Economic Evaluations for the Health Technology Assessment Submissions

    Dec 1, 2023, 00:00

  • HTA77 Is Stedi Steady? an Exploration of the Uncertainties Underlying the Quantification of the Broader Value of Antibiotics

    Dec 1, 2023, 00:00

  • HPR66 Assessing the Impact and Strategic Implications of the HTA Regulation 2021/20282 on National Processes: A Scoping Review and Stakeholders Perspectives Through Semi-Structured Interviews

    Dec 1, 2023, 00:00

  • HTA136 Analysis of the Reimbursement and Pricing of Hybrid Medicines in France

    Dec 1, 2023, 00:00

  • EE531 Resource Optimization for Greek NHS Hospitals from the Use of Daratumumab SC for Multiple Myeloma

    Dec 1, 2023, 00:00

  • RWD56 Real World Data for Planning a New Organised Cancer Screening Programme in the Czech Republic: Example of Prostate Cancer Screening

    Dec 1, 2023, 00:00

  • EE407 Economic Assessment in Resource-Constrained Systems – a Case Study Using an Individual-Level Simulation Model in Wet Age-Related Macular Degeneration and Diabetic Macular Oedema

    Dec 1, 2023, 00:00

  • MSR84 Summarizing Adverse Event Data in the Absence of High-Level Eviden The Case of Hearing Implants

    Dec 1, 2023, 00:00

  • MT16 A Review of NICE Submissions for Medical Technologies in the UK: Key Trends over the Last 2 Years

    Dec 1, 2023, 00:00

  • HPR78 From Submission to Reimbursement: Navigating the COVID-19 Ripple Effect on Therapy Access in Canada

    Dec 1, 2023, 00:00

  • EE130 Impact of Phacoemulsification Equipment in Surgical Throughput, Under the Perspective of a Greek Hospital

    Dec 1, 2023, 00:00

  • HTA108 Willingness-to-Pay for Orphan Drugs – ICER Thresholds Approved by TLV in Sweden

    Dec 1, 2023, 00:00

  • HPR43 Are There Any Common Denominators for Early Access Programs in Europe?

    Dec 1, 2023, 00:00

  • PCR46 The Current Usage and Challenges of Goal Attainment Scaling in Clinical Settings

    Dec 1, 2023, 00:00

  • EE510 Downstaging Pancreatic Cancer is Cost-Effective: Can We Achieve a Cost-Effective Early Diagnosis?

    Dec 1, 2023, 00:00

  • CO26 Efficacy of the Dupilumab 200 Mg Dose Every 2 Weeks in Children with Moderate-to-Severe Asthma during Voyage and Excursion

    Dec 1, 2023, 00:00

  • EE575 Economic Analysis of the Costs Associated With Reusable Flexible Ureteroscopes – Implications for the Utilization of Single-Use Digital Flexible Ureteroscopes

    Dec 1, 2023, 00:00

  • EPH17 The Impact of COVID-19 Preventive Restrictions on the Development of Diseases of Despair: A Multi-Group Time Series Analysis

    Dec 1, 2023, 00:00

  • EPH12 Estimating the Prevalence of Hepatitis Delta in the UK: A Migration Model Approach Applied in Practice

    Dec 1, 2023, 00:00

  • HPR33 Follow the Money: Reporting Public Contributions and Incentives on Research and Development Programs for Agenzia Italiana Del Farmaco (AIFA; ITALIAN MEDICINES AGENCY)

    Dec 1, 2023, 00:00

  • HSD56 Utilization of Vascular Assessment Before Lower Extremity Amputation Among Patients With Diabetic Foot Ulcerations in the US

    Dec 1, 2023, 00:00

  • PCR121 Insights, Needs, and Perspectives From Patients, Caregivers, and Healthcare Professionals on Shared Decision Making in Duchenne Muscular Dystrophy: A Qualitative Study

    Dec 1, 2023, 00:00

  • HSD18 Itch Intensity and Therapeutic Management of Pruritus in the Real-World Setting

    Dec 1, 2023, 00:00

  • EE222 Cost Minimization Analysis of Damoctocog Alfa Pegol in the Treatment of Severe Hemophilia A Patients in Mexico

    Dec 1, 2023, 00:00

  • RWD134 Assessing the Association between Pain Burden and Limitations Among Older United States Adults with Pain who Used Opioids

    Dec 1, 2023, 00:00

  • PCR197 Quality of Life and Duchenne Muscular Dystrophy: Greek Translation of the Pediatric Quality of Life Inventory (PEDSQL)3.0 Duchenne Muscular Dystrophy Module

    Dec 1, 2023, 00:00

  • EE675 Cost-Effectiveness Analysis of Cancer Susceptibility Gene-Specific Prevention and Surveillance Strategies for Ovarian and Breast Cancer

    Dec 1, 2023, 00:00

  • CO43 Projecting Cardiovascular Benefits Associated With Tirzepatide's Effects on Cardiovascular Risk Factors in Patients With Type 2 Diabetes in Fran A Simulation Study

    Dec 1, 2023, 00:00

  • EE45 Differing Approaches to the Health Economic Investigation of the Informal Care of People Living With Multiple Sclerosis: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • EE382 Burden and Economic Impact of Vaccine-Preventable Cancer Mortality in Europe

    Dec 1, 2023, 00:00

  • RWD104 Shifting Tides: Unveiling the Burden of Demographic Change in Germany Through Administrative Hospital Data

    Dec 1, 2023, 00:00

  • EPH227 Clinical, Economic, and Patient-Reported Impact of Obesity in Selected European Countries: A Systematic Review

    Dec 1, 2023, 00:00

  • EE55 Cost-Effectiveness of ESMO-Recommended Lenvatinib and Pembrolizumab Regimen as Second-Line Treatment for Advanced Endometrial Carcinoma in Taiwan: A Comparison With NCCN Recommendations

    Dec 1, 2023, 00:00

  • CO176 Treatment Approvals in Oncology and Relationship with Improvement in 5-Year Relative Survival for Cancer Patients in Europe

    Dec 1, 2023, 00:00

  • MSR54 COVID-19: Do All Patients Who Meet the EMA High-Risk Definition Receive Prescription?

    Dec 1, 2023, 00:00

  • EE593 Cost-Effectiveness Model of COVID-19 Vaccination: The United Kingdom Perspective

    Dec 1, 2023, 00:00

  • CO104 Identification and Selection of Biomarkers in Patient-Centric Treatment Management of Rare/Orphan Kidney Diseases: An Ongoing Research Project Aiming to Develop Personalized Treatment Algorithms

    Dec 1, 2023, 00:00

  • MSR46 Breaking Through Limitations: Enhanced Systematic Literature Reviews With Large Language Models

    Dec 1, 2023, 00:00

  • HSD53 Effect of COVID-19 Pandemic on the Delivery Time and the Point of Re-Order of Pharmaceuticals at the Logistics Services in a Governmental Hospital in Riyadh Saudi Arabia

    Dec 1, 2023, 00:00

  • PCR110 Translation and Cultural Adaptation of Clinical Outcome Assessments (COAs)—Is Machine Translation a Viable Option?

    Dec 1, 2023, 00:00

  • SA44 Clinical Burden of Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Focused Literature Review

    Dec 1, 2023, 00:00

  • HTA194 Do Health Technology Assessment (HTA) Bodies Recommend the Conduct and Submission of Artificial Intelligence-Based Literature Reviews (AILRS)?

    Dec 1, 2023, 00:00

  • MSR23 EQ-5D-5L Valuation Studies: Do the Effects of Dimensional Health Problems Interact with Each Other?

    Dec 1, 2023, 00:00

  • SA65 Trends in the Systematic Literature Reviews Over the Years

    Dec 1, 2023, 00:00

  • HPR2 Baseline Characteristics of Patients Applying for Reimbursment of Liraglutide (Saxenda®) for Weight Management Under a Managed Access Protocol in Ireland

    Dec 1, 2023, 00:00

  • HTA101 Mapping Opportunities in the Access Landscape for a New Rare Disease Treatment Option in Multiple EU Countries

    Dec 1, 2023, 00:00

  • EE723 Budget Impact of New Potassium-Lowering Therapies in the Treatment of Chronic Hyperkalemia: A Saudi Experience

    Dec 1, 2023, 00:00

  • PCR159 Considerations for Maximizing the Research Value of PRO Data Collected in Clinical Care

    Dec 1, 2023, 00:00

  • EE17 Societal Burden of Non-Alcoholic Steatohepatitis (NASH) in Denmark - Real-World Evidence from National Registries

    Dec 1, 2023, 00:00

  • PCR109 Patient Associations’ Members’ Perceptions of Level and Importance of Participation in Health Technology Assessment in Greece

    Dec 1, 2023, 00:00

  • MSR151 Causal Machine Learning for Assessing Pneumococcal Vaccine Effectiveness: Innovations in Real-World Data Analysis and Confounding Pathway Adjustment

    Dec 1, 2023, 00:00

  • HTA166 Cost-Effectiveness of Combination Pertuzumab+Trastuzumab Vs Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer (HER2+ eBC) in the Czech Republic

    Dec 1, 2023, 00:00

  • EE454 What Is the Goal of Value-Based Pricing, and to Whom Is Value Created?

    Dec 1, 2023, 00:00

  • HTA233 Transportability of Overall Survival Estimates from US to UK Populations Receiving First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

    Dec 1, 2023, 00:00

  • EE13 Using Sensor-Based Glucose Monitors Dominates Self-Monitoring of Blood Glucose for Adults with Type 1 Diabetes in the Danish Healthcare Setting

    Dec 1, 2023, 00:00

  • MT67 The Effectiveness of Body Composition Analysis Using Dual-Energy X-Ray Absorptiometry (DEXA) for Diagnosing Sarcopenia: Literature Review

    Dec 1, 2023, 00:00

  • PCR69 Understanding Determinants of the Burden Experienced by Informal Caregivers of Myasthenia Gravis Patients

    Dec 1, 2023, 00:00

  • HPR220 Assessment of the Relevance and Credibility of Indirect Treatment Comparisons (ITCs) to Help Inform Health Technology Assessment (HTA) and Reimbursement Decision-Making: Results of a 5-Country Payer Survey

    Dec 1, 2023, 00:00

  • HSD127 Impact of the COVID-19 Pandemic on Frequency of Surgeries in Germany Based on Hospital Data

    Dec 1, 2023, 00:00

  • HTA19 Insights Into NICE Technology Appraisal Outcomes in Oncology

    Dec 1, 2023, 00:00

  • EE370 Cost-Effectiveness Analysis of Pembrolizumab as Adjuvant Treatment for Resected Stage IIB/IIC Melanoma in Greece

    Dec 1, 2023, 00:00

  • RWD53 A Real-World Analysis of Treatment Patterns for First-Line Immunotherapies Among Danish Patients with Non-Small Cell Lung Cancer (NSCLC) and PD-L1 Expression ≥50%

    Dec 1, 2023, 00:00

  • EE170 A Cost-Effectiveness Analysis, with Public Healthcare Payers’ Perspective, of Oral Semaglutide Versus Luseogliflozin Hydrate for Patients with Type 2 Diabetes Mellitus in a Japanese Clinical Setting

    Dec 1, 2023, 00:00

  • EE210 Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy as Neoadjuvant Therapy and Continued as a Single Agent as Adjuvant Therapy for High-Risk Early-Stage Triple-Negative Breast Cancer in Greece

    Dec 1, 2023, 00:00

  • PCR243 Psychometric Validation of QlQ-OES18 in 2L Esophageal Squamous Cell Cancer (ESCC) Patients Treated with Tislelizumab Versus Chemotherapy

    Dec 1, 2023, 00:00

  • EE492 Economic Analysis and Outcome Research on the Effectiveness of the Return to Work Program on Occupational Injury Cases for Workers with Disabilities

    Dec 1, 2023, 00:00

  • EE427 Health Economic Decision Models Used in the Cost-Effectiveness Analyses of Innovative Products Submitted to the French National Authority for Health (HAS)

    Dec 1, 2023, 00:00

  • EE541 Cost-Effectiveness, Health-State Utility Values (HSUVs) and Cost and Resource Use (CRU) Associated with Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS): An Economic Systematic Literature Review (SLR)

    Dec 1, 2023, 00:00

  • RWD153 Economic and Humanistic Burden Among Patients With Non-Radiographic Axial Spondyloarthritis in China

    Dec 1, 2023, 00:00

  • EE737 Cost-Effectiveness Models of Continuous Glucose Monitoring in Individuals With Type 1 Diabetes: A Systematic Review on Methodology and Quality

    Dec 1, 2023, 00:00

  • EPH153 Clinical Characterization and Healthcare Resource Utilization in Adrenoleukodystrophy: A Nationwide Retrospective Cohort Using Swedish National Registries

    Dec 1, 2023, 00:00

  • EPH249 Effects of Adolescent MenACWY and MenC Vaccination in Germany: A Modelling Study

    Dec 1, 2023, 00:00

  • MSR145 Identifying Effect of a Treatment from Observational Data in Absence of Contemporaneous Control: Example of the French Study Tosca, Comparing Cemiplimab Vs. Historical Systemic Treatment in Cutaneous Squamous Cell Carcinoma

    Dec 1, 2023, 00:00

  • CO38 Real-World Comparative COVID-19 Vaccine Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 Among Immunocompromised Adults in the US

    Dec 1, 2023, 00:00

  • MT7 Barriers and Facilitators for the Use of Point of Care Diagnostics in Patients With Respiratory Tract Infections in Outpatient Care Related to the Peri-Launch Phase

    Dec 1, 2023, 00:00

  • PCR199 Value-Based Healthcare in Severe Asthma: Development of an Outcome Standard Set Pilot Study in Portugal

    Dec 1, 2023, 00:00

  • MT79 This Technology Should be Compared With? And Who for? The Digital Health Population Conundrum

    Dec 1, 2023, 00:00

  • EPH111 A Real-World Study of the Relationship between Lipoprotein(A) [Lp(A)] Concentrations and Atherosclerotic Cardiovascular Disease (ASCVD) Prognosis, Healthcare Resource Utilization and Medical Costs in Chinese Patients

    Dec 1, 2023, 00:00

  • RWD13 Treatment Pathways and Outcomes of Advanced Ovarian Cancer Patients Who Are Underrepresented in Trials

    Dec 1, 2023, 00:00

  • EPH246 Landscape of Diffuse Large B-Cell Lymphoma (DLBCL) in Brazilian Public Healthcare System (SUS)

    Dec 1, 2023, 00:00

  • CO140 Drivers of Physicians’ Treatment Decision-Making and Future Treatment Expectations: Analysis of the Adelphi Real-World Ovarian Cancer II Disease Specific Programme (DSPTM)

    Dec 1, 2023, 00:00

  • EE761 The Impact of Differences in Patient Demographics on Assessment of Long-Term Cost-Effectiveness in Cohort Level Economic Models

    Dec 1, 2023, 00:00

  • EPH49 The Short-Run and Long-Run Behavioral Effects of Vaccination Enforcement in Turkey

    Dec 1, 2023, 00:00

  • EPH112 Prevalence, Incidence, and Patient Characteristics of Valvular Heart Disease Using the National Database of Health Insurance Claims in Japan

    Dec 1, 2023, 00:00

  • PCR112 Characteristics of Individuals Living with Obesity in Germany, Weight-Loss Methods Attempted and Healthcare Resource Use over a 12-Month Period

    Dec 1, 2023, 00:00

  • EE160 Healthcare Expenditure for Treatment of Hypertension and Hypertensive Complications in Japan: A Claims Data Analysis

    Dec 1, 2023, 00:00

  • CO153 Exploring the Impact of Healthcare Provider Stress on Patient Outcomes: A Review Protocol

    Dec 1, 2023, 00:00

  • EE644 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the US

    Dec 1, 2023, 00:00

  • RWD110 Lifetime Costs of Stroke in Brazil with a Focus on Hemorrhagic Subtypes

    Dec 1, 2023, 00:00

  • HTA153 Did OS Immaturity Preclude from Receiving a Positive Recommendation: Review of Recent Oncology NICE/TA?

    Dec 1, 2023, 00:00

  • HPR87 A Comparative Analysis of Market Access Processes Between Ukraine and Germany

    Dec 1, 2023, 00:00

  • RWD119 A Decade of Alzheimer's Disease Management in Germany: The Increasing Impact of Specialists

    Dec 1, 2023, 00:00

  • EPH208 Adoption of Precision Health (PH) and Precision Medicine (PM) Approaches in Addressing Population Health Needs in Europe

    Dec 1, 2023, 00:00

  • HSD76 Assessing the Carbon Intensity Profile of an Immunization Program Against RSV in Infants in the United Kingdom to Show the Reduction in Emissions Versus Standard of Care

    Dec 1, 2023, 00:00

  • HPR151 New Proposed European Commission Pharmaceutical Regulation – Potential Changes and Impact on Biosimilars

    Dec 1, 2023, 00:00

  • CO116 The Significance of Serum Transaminases As Predictors of Mortality in Paraquat Poisoning: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • HTA336 The Danish Health Technology Council – HTA Organisations As the Nexus between Science and Policy

    Dec 1, 2023, 00:00

  • PCR255 Adherence to Single and Multiple Inhaled Triple Therapies in Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany, Considering Different Definitions

    Dec 1, 2023, 00:00

  • HTA17 Comparison of Methods for Modelling the Cost-Effectiveness of Atezolizumab as an Adjuvant Treatment in Stage II-IIIA Non-Small Cell Lung Cancer

    Dec 1, 2023, 00:00

  • EE318 Cost-Effectiveness Analysis for Soliqua in the Treatment of T2DM in Turkiye

    Dec 1, 2023, 00:00

  • PT25 Comparison of Approval Dates of New Substances Between the United States of America (Food and Drug Administration, FDA) and Europe (European Medicines Agency, EMA)

    Dec 1, 2023, 00:00

  • EE74 Cost-Effectiveness Analysis of LUNGFLAGTM Risk Prediction Model in the Selection of Individuals for Lung Cancer Screening in Spain

    Dec 1, 2023, 00:00

  • Adherence to Treatment, Patients' Preferences, and Drug Use across Multiple Diseases

    Dec 1, 2023, 00:00

  • EPH267 A Quinquennial Review of the WHO’s Global Call for Action to Eliminate Cervical Cancer - an Indian Perspective

    Dec 1, 2023, 00:00

  • EPH11 Prevalence, Risk Factors, and Characterization of Individuals with Long COVID Using Electronic Health Records in Over 1.5 Million COVID Cases in England

    Dec 1, 2023, 00:00

  • MSR56 Incorporating Background Mortality Into Survival Extrapolations: Determining the Accuracy Using a Simulation Study

    Dec 1, 2023, 00:00

  • EE708 Cost-Effectiveness of Umeclidinium/Vilanterol (UMEC/VI) Versus Aclidinium/Formoterol (ACL/FOR) in Patients with COPD in the United Kingdom

    Dec 1, 2023, 00:00

  • EE453 Projecting the Economic Benefits of the Elective Recovery Plan in England

    Dec 1, 2023, 00:00

  • EPH54 What Do the Students Think About Food Safety Knowledge at the University of Pécs?

    Dec 1, 2023, 00:00

  • HSD112 Real-World Trends in APOE Genetic Testing Associated with Lecanemab

    Dec 1, 2023, 00:00

  • HTA120 Trends in Medical Device Reimbursement Decisions in South Korea: A Novel and Comprehensive Analysis

    Dec 1, 2023, 00:00

  • HSD5 Knowledge, Attitude, and Practice of Pharmacy Professionals Against Dispensing Antibiotics Without Prescription in Ethiopia

    Dec 1, 2023, 00:00

  • EE237 The Budget Impact of Introducing Automated Hematoxylin and Eosin Staining for Cancer Diagnosis in China

    Dec 1, 2023, 00:00

  • Section 50 of the Inflation Reduction Act Drug Price Negotiation Program: Considerations for the Centers for Medicare Medicaid Services, Manufacturers, and the Health Economics and Outcomes Research Community [Editor's Choice]

    Dec 1, 2023, 00:00

  • PCR269 Detecting Changes in Relative Weighting of EQ-5D Dimensions and Levels with Sequential Analytical Hierarchy Process in Hong Kong Sar, China

    Dec 1, 2023, 00:00

  • HTA84 Is Our Evidence Enough? A Review of G-BA's Ongoing Evidentiary Requirements in the Oncology Space

    Dec 1, 2023, 00:00

  • SA57 Unmet Needs and Evidence Gaps in Relapsed/Refractory Marginal Zone Lymphoma: Findings from a Systematic Literature Review

    Dec 1, 2023, 00:00

  • RWD40 Assessing the Representativeness of Body Mass Index Categories Across Multiple Types of Secondary Data Sources

    Dec 1, 2023, 00:00

  • HPR98 Examining Reimbursement and Pricing Decisions of Oncohematological Medicines in Spain

    Dec 1, 2023, 00:00

  • HSD24 Digital Medical Services Delivered by Internet Hospitals via WeChat in China: A Qualitative Analytical Research

    Dec 1, 2023, 00:00

  • EE433 Cost and Duration of Hospital Stays for Complex Patients Receiving a Micra or a Conventional Pacemaker With Epicardial Leads in France

    Dec 1, 2023, 00:00

  • HTA347 Exploration of the Factors Driving Decisions of the Transparency Commission Based on an Analysis of HAS Meeting Transcripts Using Natural Language Processing

    Dec 1, 2023, 00:00

  • EE597 Data on Human Population Mobility in Individual-Based Models of Infectious Disease Transmission: A Systematic Review

    Dec 1, 2023, 00:00

  • CO14 Identification Use of Prognostic Variables (PVs)/Treatment Effect Modifiers (TEMs) in Indirect Treatment Comparisons (ITCs) By Systematic Literature Review (SLR): Case Study of Chimeric Antigen Receptor (CAR) T-Cell Therapies

    Dec 1, 2023, 00:00

  • HSD113 Access to Medicines, Care, and Services for Multiple Sclerosis Patients in Central and Eastern European Countries: A Comparative Analysis

    Dec 1, 2023, 00:00

  • EE339 Use of Dalbavancin in the Treatment of Pediatric Acute Bacterial Skin and Skin Structure Infections in the Spanish Hospital Setting: A Comparative Cost Analysis

    Dec 1, 2023, 00:00

  • MSR94 Harnessing AI in Health Economics: Enhancing Efficiency, Accuracy, and Decision-Making

    Dec 1, 2023, 00:00

  • HTA151 Subjective Well-Being and Mental Health During the COVID-19 Pandemic in Hungary

    Dec 1, 2023, 00:00

  • SA6 Cost-of-Illness of Skin Cancer: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • RWD180 Analyzing Medical Patterns and Catastrophic Health Expenses in Occupational Injuries Victims in South Korea

    Dec 1, 2023, 00:00

  • CO97 Real-World Outcomes in Third-Line and Beyond (3L+) Small-Cell Lung Cancer (SCLC): A Systematic Literature Review (SLR)

    Dec 1, 2023, 00:00

  • EPH47 Modeling the Impact of the Vaccine Candidate TAK-003 on the Incidence of Dengue in French Overseas Territories

    Dec 1, 2023, 00:00

  • HSD12 Hepatocellular Carcinoma Patient Pathway in Portugal – From Diagnosis to Treatment – Results From Opal Study

    Dec 1, 2023, 00:00

  • PT20 Applications for Tolvaptan (JINARC®) Under a Managed Access Protocol in Ireland

    Dec 1, 2023, 00:00

  • HTA197 Increasing Patient Access in Scandinavia Through Outcome Based Agreements: Can the Spanish Model be Replicated?

    Dec 1, 2023, 00:00

  • PCR23 Patient Preferences for Treatment Attributes and Endpoints in Neoadjuvant Therapy for Early-Stage Breast Cancer

    Dec 1, 2023, 00:00

  • HPR116 Is Payment Innovation Keeping Up With Therapy Innovation? A New Taxonomy of Innovative Payment Solutions to Aid Effective Implementation

    Dec 1, 2023, 00:00

  • HTA107 Are All Unmet Needs Valued the Same? A Review of Disease Prioritization and Related Resource Allocation in Europe

    Dec 1, 2023, 00:00

  • P26 Drug Utilization, Adherence, and Persistence in Parkinson's Disease Patients in a Real-World Setting in Quebec, Canada

    Dec 1, 2023, 00:00

  • EE219 Lorlatinib as a First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis in Greece

    Dec 1, 2023, 00:00

  • CO69 Evidence Gap Analysis of the Burden of Illness and Treatment of Bullous Pemphigoid

    Dec 1, 2023, 00:00

  • EE116 Quantifying the Future Impact of Chronic Kidney Disease Screening Programs in Belgium

    Dec 1, 2023, 00:00

  • HTA314 A Review of Pediatric Medicines Assessed by NICE Between 2018 and 2023

    Dec 1, 2023, 00:00

  • EE624 The Economic Burden of Macrovascular Complications of Diabetes in Algeria

    Dec 1, 2023, 00:00

  • HTA22 Access to Orphan Pediatric and Adolescent Medicinal Products in Greece Over 4 Years (2018-2021)

    Dec 1, 2023, 00:00

  • HTA267 Is the BBC Truly Impartial When Reporting on NICE’s Activities?

    Dec 1, 2023, 00:00

  • HPR216 Multi-Stakeholder Perspectives on Interpretation, Challenges, and Ways Forward for the Unmet Medical Need Concept – Semi-Structured Interviews

    Dec 1, 2023, 00:00

  • EE73 Ocean (OP-103): Patients with Relapsed/Refractory Multiple Myeloma Treated with Melflufen Plus Dexamethasone or Pomalidomide Plus Dexamethasone - a Resource Utilization Analysis of Adverse Events Leading to Hospitalizations

    Dec 1, 2023, 00:00

  • PCR117 A Qualitative Interview Study into the Experiences of Fatigue and Depression in Chronic Hepatitis B

    Dec 1, 2023, 00:00

  • HPR3 Burden of HIV/AIDS Assessment and Forecast for 2030 in Turkiye

    Dec 1, 2023, 00:00

  • CO10 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Secukinumab at 52 Weeks for the Treatment of Psoriatic Arthritis

    Dec 1, 2023, 00:00

  • RWD41 Utilization Patterns of Glucagon-like Peptide Receptor Agonists in Patients with Type 2 Diabetes in France and Italy

    Dec 1, 2023, 00:00

  • HSD61 The Diagnostic Journey of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Dementia, and the Importance of Biomarker Testing for Timely Diagnosis: A Real-World Survey in Europe

    Dec 1, 2023, 00:00

  • HTA91 5 Years of CAR-T Cell Therapies—Comparison of German AMNOG Dossiers in Terms of Available Evidence and Price Development

    Dec 1, 2023, 00:00

  • EE249 Cost and Outcomes of Teduglutide in Adult Patients With Short Bowel Syndrome—Is the Combination With BSC Cost-Effective for the Society?

    Dec 1, 2023, 00:00

  • EE268 Healthcare Costs and All-Cause Mortality Following a Hyperkalemia Event and Reduction of RAASi Therapy in Sweden

    Dec 1, 2023, 00:00

  • MSR92 Can Artificial Intelligence (AI) Large Language Models (LLMS) Such as Generative Pre-Trained Transformer (GPT) Be Used to Automate Literature Reviews?

    Dec 1, 2023, 00:00

  • HTA281 Environmental Considerations in HTA: Can HTA Bodies Contribute to Environmental Sustainability?

    Dec 1, 2023, 00:00

  • MT24 Digital Therapeutics (DTX): Market Access Challenges and Stakeholder Perspectives in Germany

    Dec 1, 2023, 00:00

  • EE754 Is the Paradigm Shifting? The REvalMED Pilot Program and Subsequent Integration of Economic Evaluations to Influence Pricing and Reimbursement Discussions in Spain

    Dec 1, 2023, 00:00

  • EE190 How Many Patients Diagnosed with Mild Cognitive Impairment Are Willing to Pay for a PET Scan to Receive the Treatment for Alzheimer′S Disease in Japan?

    Dec 1, 2023, 00:00

  • EPH200 Healthcare Resource Consumption of Patients with Chronic Obstructive Pulmonary Disease Treated with Triple and Dual Therapy and Experiencing an Acute Exacerbation

    Dec 1, 2023, 00:00

  • HPR41 Linking the Price of a Drug to Its Real-Life Performan A Solution for Financing Innovative Therapies in France?

    Dec 1, 2023, 00:00

  • HTA23 Reasons for a Negative Pharmaceutical Benefits Advisory Committee (PBAC) Review in Rare Diseases in Australia: A Comprehensive Analysis

    Dec 1, 2023, 00:00

  • HTA292 Implications of EU HTA on Future Relevance of Surrogate Outcomes in National Assessment

    Dec 1, 2023, 00:00

  • EE263 Economic and Healthcare Burden of Blood Transfusions in Transfusion-Dependent Beta-Thalassemia in Thailand and Brazil

    Dec 1, 2023, 00:00

  • P19 Demographics of Patients and Societal Burden of Obstructive Hypertrophic Cardiomyopathy: Results From a Real-World Survey in Italy and Spain

    Dec 1, 2023, 00:00

  • EE106 Artificial Intelligence (AI) Based Telemedicine for Cost-Effective Cataract Surgery Follow-up at NHS: An Economic Evaluation

    Dec 1, 2023, 00:00

  • EE223 Estimation of the T-Cell Engagers (Bi-Specific Monoclonal Antibodies and Chimeric Antigen Receptor [CAR T-CELL]) Therapy Administration Pathways From French Hospitals and National Health Insurance Perspective and Financial Impact

    Dec 1, 2023, 00:00

  • MSR42 A Parametric Method for Unanchored Matching-Adjusted Indirect Treatment Comparison (MAIC) Based on Survival Outcomes for Health Economic (HE) Models in Absence of Proportional Hazards (PH)

    Dec 1, 2023, 00:00

  • EE234 Economic Analysis of the Pronto Study

    Dec 1, 2023, 00:00

  • RWD57 Treatment Patterns and Cost of Care Among Patients With Metachromatic Leukodystrophy (MLD) in the US

    Dec 1, 2023, 00:00

  • EE85 Health System Costs and Resources for Stage-Specific Breast Cancer: A Population-Based Approach (Updated)

    Dec 1, 2023, 00:00

  • MT28 Physician Experiences and Preferences in Peripheral Bronchoscopy for Diagnosing Patients with Solitary Pulmonary Nodules Suspected of Lung Cancer: A Multi-Country, Cross-Sectional Survey

    Dec 1, 2023, 00:00

  • EE15 Cost-Effectiveness Analysis of Oral Semaglutide as the Second-Line and Third-Line Treatment for Type 2 Diabetes Patient

    Dec 1, 2023, 00:00

  • EE144 Decision Modifiers Under Uncertainty: Comparison of Deterministic and Probabilistic Methods in Disease Severity Classification by NICE

    Dec 1, 2023, 00:00

  • HTA284 Early Access in Fran Descriptive Analysis of Eap Decisions Two Years after the Reform

    Dec 1, 2023, 00:00

  • EE615 A Cost-Effectiveness Analysis of the CNIC-Polypill Strategy, Compared to Usual Care, in Secondary Cardiovascular Prevention from a Spanish Perspective Using Data from the Secure Trial

    Dec 1, 2023, 00:00

  • HTA226 Can Prior Indirect Treatment Comparisons (ITCs) Inform Health Technology Assessment (HTA) Strategy: A Case Study in Relapsed-Refractory Diffuse Large B Cell Lymphoma (RR-DLBCL)

    Dec 1, 2023, 00:00

  • EE367 The Use of Genomic Tests for Early Breast Cancer in Finland Is Likely to be Cost-Effective at Common WTP Threshold

    Dec 1, 2023, 00:00

  • EE429 Current Parallel Trade Practice in the Pharmaceutical Industry Focusing on European Single Market, Utilizing a Cost-Saving Analysis in the Allergen Immunotherapy Market of Germany

    Dec 1, 2023, 00:00

  • HPR63 Plasma Last Liter Economics and Its Impact on the Costs of Major Human Polyvalent Immunoglobulins in Europe

    Dec 1, 2023, 00:00

  • HSD45 Atopic Dermatitis’ Treatment Patterns in Latin America: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • PCR60 Shared Decision Making in Inflammatory Bowel Disease Clinical Practi What Are the Experiences, Barriers, and Opportunities According to Patients and Healthcare Professionals?

    Dec 1, 2023, 00:00

  • HTA251 Unraveling the Relationship between Expedited Regulatory Approval By the European Medicines Agency (EMA) and Reimbursement Outcomes for Drugs Approved Under Exceptional Circumstances

    Dec 1, 2023, 00:00

  • EE655 Patients Level Cost of Treating Adverse Events in Alzheimer’s Disease for US-FDA Approved Treatments

    Dec 1, 2023, 00:00

  • PCR90 Hypoglossal Nerve Stimulation (HGNS) for Obstructive Sleep Apnea (OSA): A Systematic Review and Meta-Analysis of Patient-Reported Outcomes

    Dec 1, 2023, 00:00

  • P39 Machine Learning to Identify Atopic Dermatitis Prevalence Using Healthcare Utilisation Patterns of Both Diagnosed and Non-Diagnosed AD Patients Based on Danish Register Data

    Dec 1, 2023, 00:00

  • PCR208 Pace CKD Financial Burden and Work Productivity Assessment of Chronic Kidney Disease on Patients: Results from an International Survey

    Dec 1, 2023, 00:00

  • EE466 Economic Evaluation of Improving Medication Adherences for Secondary Cardiovascular Disease Prevention: A Threshold Analysis

    Dec 1, 2023, 00:00

  • PCR264 Impact of Sodium Glucose Cotransporter-2 Inhibitors (SGLT2is) on Health-Related Quality of Life (HRQoL) Outcomes in Adult Patients With Type 2 Diabetes Mellitus (T2DM)

    Dec 1, 2023, 00:00

  • HTA81 Exploring the Gap Between Regulatory Labels and Reimbursed Indications of Oncology Drugs in the Netherlands

    Dec 1, 2023, 00:00

  • EPH107 Predictors and Consequences of Pediatric Nurses' Burnout: An Integrative Review

    Dec 1, 2023, 00:00

  • RWD23 Comparison of the Use of Real-World Evidence (RWE) by Health Technology Assessment (HTA) Agencies in Reviews of Drugs for Rare Diseases (DRDS)

    Dec 1, 2023, 00:00

  • SA43 Methods of Estimating Annualized Bleed Rates from Medical Records Among Patients with Hemophilia A

    Dec 1, 2023, 00:00

  • EPH114 Clinical Characteristics, Average Cost Per Visit, and Major Adverse Cardiovascular Events in Patients with Diagnosed Chronic Kidney Disease Combined with Cardiovascular Disease: A Study from a Large Healthcare Database in China

    Dec 1, 2023, 00:00

  • MSR149 Cost-Effectiveness Model Conceptualisation in Chronic Graft Versus Host Disease

    Dec 1, 2023, 00:00

  • EE669 Quality of Life and Economic Burden of Advanced Non-Small Cell Lung Cancer in Medium and Small Markets (MEDSM): A Systematic Literature Review

    Dec 1, 2023, 00:00

  • EE133 Potential Budget Impact of Negative Pressure Wound Therapy (NPWT) Versus Conventional Wound Treatment (CWT) in Diabetic Foot Ulcers (DFU), Surgical Abdominal Wounds with Healing Impairment (SAWHI), and Trauma Wounds for Mexico

    Dec 1, 2023, 00:00

  • RWD48 Identification and Assessment of Real-World Oncology Data in China: A Data Landscaping Study

    Dec 1, 2023, 00:00

  • HSD23 Health Technology Management - The Future of the Post-Reimbursement Phase?

    Dec 1, 2023, 00:00

  • EE476 Cost Analysis of Patiromer Versus Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia in the UK, Italy and Spain

    Dec 1, 2023, 00:00

  • HSD73 Establishing a Learning Healthcare System for Metastatic Prostate Cancer in the Dutch Healthcare System: Preconditions and Potential Benefits of Real-World Data Utilization

    Dec 1, 2023, 00:00

  • EE157 The Societal Impact of Inclisiran Using Population Health Approaches Across 15 Countries

    Dec 1, 2023, 00:00

  • EE96 Resource Consumption Analysis in Patients with Hemophilia A Without Inhibitors on Prophylaxis with FVIII Before Switching to Emicizumab

    Dec 1, 2023, 00:00

  • The Impact of Cost-Containment Initiatives from across the Globe

    Dec 1, 2023, 00:00

  • HTA230 Comparative Evaluation of the Performance of Two Value Attribution Frameworks When Applied to Combination Regimens in Oncology

    Dec 1, 2023, 00:00

  • EE252 The Economic Implication of Sinus Rapid Relief Pathway in Italy: Awake Surgery Vs General Anesthesia to Guarantee Quick Access to Patients Who Needs Sinus Surgery

    Dec 1, 2023, 00:00

  • EPH73 Modelling the Wider Socio-Economic Costs of Problematic Opioid Use in Germany

    Dec 1, 2023, 00:00

  • EE638 Cost-Effectiveness of Vasopressin Alone or in Combination With SOC in the Treatment of Sepsis and Septic Shock Patients

    Dec 1, 2023, 00:00

  • EPH88 Human Papillomavirus (HPV) Vaccination Coverage Among French Adolescents: Papillon Study

    Dec 1, 2023, 00:00

  • EPH18 Incidence of Postpartum Mental and Behavioral Disorders in Japan

    Dec 1, 2023, 00:00

  • MSR136 IPECAD Modeling Workshop 2023 Cross Comparison Challenge on Cost-Effectiveness Models in Alzheimer's Disease and Related Dementias

    Dec 1, 2023, 00:00

  • HTA200 Review of Population-Adjusted Indirect Treatment Comparison Methods in NICE Non-Oncology Appraisals

    Dec 1, 2023, 00:00

  • MSR66 Natural Language Processing to Support the Abstract Selection During Systematic Literature Review

    Dec 1, 2023, 00:00

  • EE589 Use of Copulas for Correlated Sampling of Cost and Utility Parameters During Probabilistic Sensitivity Analysis for Cost-Effectiveness Analyses

    Dec 1, 2023, 00:00

  • EE532 A Conceptual Model for the Cost Effectiveness of Artificial Intelligence-Assisted Chest Computed Tomography (CT) to Detect Lung Nodules and Improve Decision Making

    Dec 1, 2023, 00:00

  • HTA92 A Targeted Review of Methods for Effect Modifier (EM) and Prognostic Factor Identification in Population Adjusted Indirect Comparisons (PAICs) in NICE Oncology Submissions

    Dec 1, 2023, 00:00

  • EPH256 Healthcare Resource Utilization and Related Cost Among Patients Hospitalized for Prurigo Nodularis: A Retrospective Cohort Study Using Italian Health Claims Data

    Dec 1, 2023, 00:00

  • HTA218 Public Engagement and Its Influence on Health Technology Assessment Outcomes in Latin America

    Dec 1, 2023, 00:00

  • EE311 Starts with Sacubitril/Valsartan in the Inpatient Vs Outpatient Setting in Spain

    Dec 1, 2023, 00:00

  • EE271 Cost-Effectiveness of Finerenone in Addition to Standard-of-Care in Treating Type 2 Diabetes and Chronic Kidney Disease in China

    Dec 1, 2023, 00:00

  • PCR80 Patient Preferences for Stages II/III and Stage IV Melanoma Treatments in the UK

    Dec 1, 2023, 00:00

  • RWD61 Inclusion of Productivity Losses and Gains in Cost-Effectiveness Analyses in Psoriasis: Preliminary Report of a Brazilian Association of Psoriasis (LATAM/LMIC)

    Dec 1, 2023, 00:00

  • HTA145 Similarity of Guidelines for Direct and Indirect Comparisons Under Eunethta and Country-Specific HTA – Implications for Supportive Agents

    Dec 1, 2023, 00:00

  • EPH137 Healthcare Resource Consumption and Direct Costs of Patients Newly Diagnosed with Acute Myeloid Leukemia from a Large Italian Administrative Database

    Dec 1, 2023, 00:00

  • PCR9 Rise of Undiagnosed Major Depressive Disorder Post-COVID-19 Pandemic in Europe

    Dec 1, 2023, 00:00

  • MT68 Digital Therapeutics (DTx) for Alzheimer's Disease, Dementia and Mild Cognitive Impairment: A Pragmatic Review of Clinical Evidence

    Dec 1, 2023, 00:00

  • PCR274 Patient Data Use in Medical Research Vs Data Privacy: Perspective from Five Patient Association Representatives

    Dec 1, 2023, 00:00

  • HSD63 New Pathway in Anti-HER2 Treatments’ Administration in Breast Cancer in Fran Which Impacts of the Involvement of an Advanced Practice Nurse in Hospital at Home Program?

    Dec 1, 2023, 00:00

  • HTA300 How Fast Will the EU HTA Child Grow? Estimation of the Number of Procedures in the First Years of Implementation

    Dec 1, 2023, 00:00

  • SA8 The Use of Care Pathway Analysis to Inform Health Economic Models and Evidence Generation Requirements: Practical Applications and Examples from Two Projects

    Dec 1, 2023, 00:00

  • EPH7 Estimating the Projected Impact of Weight Loss on Obesity Prevalence and Healthcare Costs in a UK Population

    Dec 1, 2023, 00:00

  • RWD158 Estimates on Waste of Breast Cancer Related Chemotherapy Drugs in the NHS (ENGLAND)

    Dec 1, 2023, 00:00

  • HTA279 Retrospective Analysis of the French Early Access Experience Following the 2021 Reform

    Dec 1, 2023, 00:00

  • PCR82 Hierarchical Clustering of Rare Diseases Based on Functional Impacts to Support the Identification of Potential Patient-Centered Outcomes Measures for Rare Diseases Research

    Dec 1, 2023, 00:00

  • MSR63 Implementing Simple Active Learning (AL) Boosters Considerably Improves the Early Identification of Relevant Studies in the Systematic Literature Review (SLR) Process

    Dec 1, 2023, 00:00

  • HPR144 Support of RWE in the Price and Reimbursement Decision-Making Process for Rare Diseases in Spain

    Dec 1, 2023, 00:00

  • EE395 Economic Burden and Cost Drivers of Dystrophic Epidermolysis Bullosa: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • HTA3 Health Technology Assessment Requirements: Sensitive to Bacteriophage Products or Too Resistant to Change?

    Dec 1, 2023, 00:00

  • CO6 Teduglutide for Treating Short-Bowel Syndrome in Adults: A Meta-Analysis of Real-World Evidence Compared to Clinical Trial Data

    Dec 1, 2023, 00:00

  • HTA257 Key HTA Learnings from Approved Gene Therapies Across the EU4, England, and the US

    Dec 1, 2023, 00:00

  • RWD92 Evaluation of Second and Third Generation Tyrosine Kinase Inhibitor As First-Line Therapy for Non–Small-Cell Lung Cancer Patients: A Multi-Institutional Study in Taiwan

    Dec 1, 2023, 00:00

  • EE722 Cost-Utility Analysis for Haemate-P in the Treatment of Von Willebrand Disease

    Dec 1, 2023, 00:00

  • Cover

    Dec 1, 2023, 00:00

  • EE747 Cost-Utility Analysis of 15-Valent Pneumococcal Conjugate Vaccine in the Immunization of Adults Over 65 Years of Age in the Czech Republic

    Dec 1, 2023, 00:00

  • HTA31 Health Technology Assessment (HTA) of Clinical Care Pathways: Peritoneal Dialysis Versus Hemodialysis

    Dec 1, 2023, 00:00

  • PCR86 Estimating Health-Related Quality of Life in Fabry Disease for Patients Treated with Enzyme-Replacement Therapy in the BALANCE Randomized Controlled Trial

    Dec 1, 2023, 00:00

  • HTA334 Assessment of Vaccines in Europe, the HPV Example: Can the EU Joint Clinical HTA Regulation Result in More Consistent Vaccine Evaluations and Improve Access Across EU Countries?

    Dec 1, 2023, 00:00

  • HTA294 Using Machine Learning to Predict HTA Approval: Importance of Patient Subgroup Specification Within Obesity

    Dec 1, 2023, 00:00

  • PCR44 Work and Activity Impairment in Individuals With Chronic Kidney Disease According to Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Use

    Dec 1, 2023, 00:00

  • PCR239 Quality of Life (QOL) Instruments Used in Clinicaltrials.gov-Indexed Trials of Gene-Modified Cell Therapy (GMCT) in Patients With Multiple Myeloma (MM)

    Dec 1, 2023, 00:00

  • RWD86 Characteristics of Patients with Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Who Received Pembrolizumab as Part of an Early Access Program in Accordance with KN-355 Labelling

    Dec 1, 2023, 00:00

  • PCR206 Characterization of the Lupus Patient Experience Based on Longitudinal Patient Generated Real World Data from a Digital Health App (HEALTH STORYLINES)

    Dec 1, 2023, 00:00

  • HTA93 Time to Reimbursement of Novel Anticancer Drugs in Ireland Compared to Six European Countries and the UK

    Dec 1, 2023, 00:00

  • EE402 Cost Effectiveness Analysis of Levonorgestrel Vs Etonorgestrel in Contraception from the Mexican Context

    Dec 1, 2023, 00:00

  • HTA66 Review and Analysis of Economic Model Characteristics According to Published HTA Conclusions in Ukraine

    Dec 1, 2023, 00:00

  • HTA340 Is There Equity of Access to Highly Specialized Treatments Between England and Northern Ireland?

    Dec 1, 2023, 00:00

  • EE592 Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Filipino Adults Aged ≥50 Years

    Dec 1, 2023, 00:00

  • EPH25 Impact of Cancer Deaths on Years of Life and Productivity Losses in Japan in 2019

    Dec 1, 2023, 00:00

  • EE363 Cost-Effectiveness Analysis of Adding Tumor Treating Fields Therapy to Temozolomide Versus Temozolomide Only in Patients with Glioblastoma in France

    Dec 1, 2023, 00:00

  • EE167 Budget Impact Analysis of Sensor Augmented Pump Therapy for Type 1 Diabetes (T1D) in Bulgaria

    Dec 1, 2023, 00:00

  • EE746 Cost-Effectiveness of Vaccination Strategies to Control Future Mpox Outbreaks in England

    Dec 1, 2023, 00:00

  • MSR59 Does Interval Time-Trade-Off Reduce Satisfying Effects and Inconsistencies in Valuation Studies?

    Dec 1, 2023, 00:00

  • MSR141 Identifying and Extrapolating Immature OS Data in Survival Analysis: A Review of the Variation in Methods Used in Oncology STAs for NICE

    Dec 1, 2023, 00:00

  • PCR42 Humanistic Burden of Paroxysmal Nocturnal Hemoglobinuria from the Patient Perspective: Results from a Cross-Sectional Study

    Dec 1, 2023, 00:00

  • SA18 Public Health Economic Modelling in Evaluations of Salt and Alcohol Policies: A Scoping Review

    Dec 1, 2023, 00:00

  • HTA328 An Updated Analysis of the Early Access Reform and Trends Observed in the Evaluation by the HAS

    Dec 1, 2023, 00:00

  • EE196 Real World Evidence on the Burden of Disease for Patients and Their Nearest Relatives - the Case of Duchenne Muscular Dystrophy

    Dec 1, 2023, 00:00

  • OP28 Are Best Practice Methods for Expert Elicitation Being Applied in NICE Highly Specialized Technology (HST) Submissions? A Review and Evaluation

    Dec 1, 2023, 00:00

  • CO48 A Systematic Review of Effectiveness and Safety of Acupuncture on Suicidal Behavior

    Dec 1, 2023, 00:00

  • EPH181 Are Social Networks Harming Our Teens? Assessing the Plausibility of a Link between Social Network Use and Depression Using a Microsimulation Model

    Dec 1, 2023, 00:00

  • P35 How Perspective Affects the Cost-Effectiveness of Remote Patient Monitoring for Patients With Heart Failure in Different European Countries

    Dec 1, 2023, 00:00

  • PCR26 Testing the Psychometric Properties of Several Euroqol Instruments for Measuring the Impact of COVID-19 in a Large Sample of Chinese Children and Their Parent Carers

    Dec 1, 2023, 00:00

  • CO114 Comparative 30-Day Postoperative Outcomes between Robotic-Assisted Low Anterior Resection (RALAR) and Laparoscopic Low Anterior Resection (LLAR) Among Rectal Cancer Patients in Japan

    Dec 1, 2023, 00:00

  • EE535 Assessing the Impact of Adverse Events on Cost-Effectiveness Results for NICE Single Technology Appraisals of Oncology Medicines

    Dec 1, 2023, 00:00

  • PCR34 The Humanistic and Economic Burden of Illness in Progressive Fibrosing Idiopathic Lung Disease: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • HPR188 Orphan Drugs – How Will the New Proposed European Union (EU) Commission Pharmaceutical Regulation Impact Therapies for Rare Diseases?

    Dec 1, 2023, 00:00

  • HPR8 Drug Approvals for Advanced Breast Cancer in Brazil: Historical Perspective and Comparative Cost-Effectiveness Analysis

    Dec 1, 2023, 00:00

  • HSD27 A 2013-2019 Comparative Study of Patient Safety Culture at 16 Hospitals in Shimane, Japan

    Dec 1, 2023, 00:00

  • HPR160 An Ecological Study of 4 Drug Categories Consumption Inequities in Spain

    Dec 1, 2023, 00:00

  • HPR167 Neutralizing Efficacy of Expired Snake Antivenoms: A Systematic Review of Preclinical Studies and Real-World Experience

    Dec 1, 2023, 00:00

  • PCR33 The Application of Stated Preference Methods in Rare Disease: A Systematic Review

    Dec 1, 2023, 00:00

  • CO65 Modelled Impact of Nirsevimab for All Infants in the Prevention of Respiratory Syncytial Virus (RSV): Related Hospitalizations and Its Predicted Cost to the Brazilian Public Healthcare System

    Dec 1, 2023, 00:00

  • HTA147 Similarities and Differences Between the HTA Methods for Indirect Comparisons in the EU Joint Clinical Assessment and National Assessments by Member States

    Dec 1, 2023, 00:00

  • HPR148 Bio-Hybrid Medicinal Products: Widening Access or Product Differentiation?

    Dec 1, 2023, 00:00

  • HTA29 Analysis of the Change of the Added Benefit and Respective Reasons in Renewed Regular Benefit Assessments of Orphan Drugs Due to Exceeding the Sales Threshold in Germany

    Dec 1, 2023, 00:00

  • PCR232 Psychometric Properties of a Patient Reported Outcome Measure (PROM) Evaluating Patient Autonomy in Multiple Sclerosis (MS)

    Dec 1, 2023, 00:00

  • HTA195 Optimized Recommendations in NICE Technology Appraisals: Permissive or Restrictive?

    Dec 1, 2023, 00:00

  • MSR88 Validation of a Programmed Probability Score Using the Screening Tool, Sympro to Assist Selection of Studies in Systematic Literature Reviews

    Dec 1, 2023, 00:00

  • EPH34 Knowledge on HPV and Vaccination Among Undergraduates in Vojvodina

    Dec 1, 2023, 00:00

  • EE291 Budget Impact Analysis of Mrna-1273 (Spikevax) in Patients with COVID-19 in Bulgaria

    Dec 1, 2023, 00:00

  • EE544 The Impact of Pulmonary Arterial Hypertension in the Brazilian Public Healthcare System: A Microcosting Approach Based on Expert's Opinion

    Dec 1, 2023, 00:00

  • HSD86 Economic Attributes of Caregiver Burden Among Schizophrenia Patients: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • EPH85 Clinical Burden of GM2 Gangliosidoses in the United States (US): A Retrospective Observational Cohort Study Using Electronic Health Records (EHR)

    Dec 1, 2023, 00:00

  • EE528 Analysis of Non-Pharmacological Cost Savings Derived from the Use of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients with HER2-Positive Breast Cancer in Spain

    Dec 1, 2023, 00:00

  • CO187 Relative Effectiveness of Faricimab Vs Aflibercept 8 Mg after Loading Phase in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

    Dec 1, 2023, 00:00

  • EE285 Economic Evaluation of Knee Arthroscopic Surgery: A Comparison of Ambulatory and In-Patient Knee Arthroscopic Surgery in Thailand

    Dec 1, 2023, 00:00

  • HPR191 Incentives for Using Biosimilars in France and Europe: Analysis, Assessment and Perspectives

    Dec 1, 2023, 00:00

  • EE337 Cost-Effectiveness of Nirmatrelvir/Ritonavir in High-Risk Swedish Adults Including Post-Acute COVID Syndrome (PACS) From a Societal Perspective

    Dec 1, 2023, 00:00

  • EE227 Waldenstrom's Macroglobulinemia: An Overview of Treatment Patterns, Resource Use, and Costs From the Brazilian Private Healthcare Perspective

    Dec 1, 2023, 00:00

  • EE134 Pharmacoeconomic Evaluation of National Immunization Program Realisation in Algeria

    Dec 1, 2023, 00:00

  • HTA123 The View from the Sandbox: Implementing a Safe Space to Co-Develop and Test Innovations in HTA

    Dec 1, 2023, 00:00

  • MSR126 AutoCriteria: Advancing Clinical Trial Study With AI-Powered Eligibility Criteria Extraction

    Dec 1, 2023, 00:00

  • PCR51 Patient-Centered Instrument Design: Problems and Solutions Based on Patient Feedback

    Dec 1, 2023, 00:00

  • PCR134 Listening and Learning from the Voices of Patients with Myelodysplastic Syndromes and Their Caregivers: A Comprehensive Social Media Analysis Using Machine Learning and Natural Language Processing-Based Algorithms

    Dec 1, 2023, 00:00

  • EE262 Indirect Cost Burden for Individuals Living with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in Europe

    Dec 1, 2023, 00:00

  • PCR81 Diagnosis and Treatment Patterns in European Patients with Systemic Mastocytosis

    Dec 1, 2023, 00:00

  • HPR77 Community-Based Health Insurance and Migrant Organizations: Senegalese Associations’ Response to Legal Vulnerability and Transnational Medical Needs

    Dec 1, 2023, 00:00

  • EE37 Method Matters: Cost-Minimization Versus Cost-Effectiveness Frameworks in Assessing Opioid Use Disorder Treatments

    Dec 1, 2023, 00:00

  • PCR178 Illness-Related Uncertainty in Relapsing-Remitting Multiple Sclerosis: Psychometric Properties of the MUIS Questionnaire

    Dec 1, 2023, 00:00

  • P4 Testing SimPy, a Library for Patient-Level Simulations in Python: An Application to Resource Management in Healthcare Systems

    Dec 1, 2023, 00:00

  • EE232 Cost-Effectiveness of a Genomic Profiling Test for HRD Determination in Ovarian Cancer Into the Current Clinical Practice for Platinum-Sensitive Patients With Advanced Ovarian Cancer in Greece

    Dec 1, 2023, 00:00

  • EE204 Saving Lives through Early Access: Exploring the Impact of a Managed Access Agreement in Adjuvant EGFRm NSCLC

    Dec 1, 2023, 00:00
  • «
  • 21
  • 22
  • 23
  • 24
  • 25 (current)
  • 26
  • 27
  • 28
  • 29
  • 30
  • »